{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T07:04:12Z","timestamp":1784531052426,"version":"3.55.0"},"reference-count":22,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2026,7,19]],"date-time":"2026-07-19T00:00:00Z","timestamp":1784419200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medical Sciences"],"abstract":"<jats:p>Background: Acute diverticulitis (AD) is a prevalent gastrointestinal disorder with a significant recurrence rate. Faecal calprotectin (FC) is a non-invasive biomarker of intestinal inflammation, but its role in diagnosing and monitoring diverticulitis remains to be fully established. Objective: This narrative review aims to evaluate the current evidence on the utility of FC in the diagnosis, severity assessment, prediction of recurrence, and monitoring of therapeutic response in patients with diverticular disease (DD) and AD. Methods: A structured literature search was conducted using PubMed, Scopus, and ScienceDirect for peer-reviewed original studies published in English between 2004 and April 2025. The search strategy combined terms related to diverticular disease and faecal calprotectin. Studies reporting original data on FC in DD were synthesised narratively. Results: FC demonstrates significant utility across multiple clinical applications in DD. For diagnosis, FC is markedly elevated in AD (mean 556\u2013695 \u03bcg\/g) and symptomatic uncomplicated diverticular disease (SUDD) (median 181 \u03bcg\/g), while remaining normal in irritable bowel syndrome (mean 50 \u03bcg\/g), enabling differentiation between organic and functional disorders. FC correlates strongly with endoscopic disease severity, with positivity rates increasing from 48.6% in DICA 1 to 93.2% in DICA 3 (p &lt; 0.0001). For predicting recurrence, elevated FC identifies patients at high risk, with one study reporting 87.5% of recurrent cases showing prior FC elevation and a negative predictive value of 96.8%. FC also exhibits excellent short-term prognostic capacity (AUC 0.976 at 3 months) and responds to therapeutic intervention, with significant reductions following successful treatment with probiotics, nutraceuticals, budesonide, and other agents. Conclusions: FC is a promising non-invasive biomarker for diagnosing diverticulitis, assessing disease severity, predicting recurrence, and monitoring treatment response. Its ability to detect subclinical inflammation makes it particularly useful for risk stratification. However, the current evidence base consists predominantly of retrospective and observational studies, and standardised thresholds require further validation through prospective trials before routine clinical implementation can be recommended.<\/jats:p>","DOI":"10.3390\/medsci14030406","type":"journal-article","created":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:09:09Z","timestamp":1784527749000},"page":"406","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Faecal Calprotectin: A Non-Invasive Marker for Diagnosing and Monitoring Acute Diverticulitis"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-3216-3682","authenticated-orcid":false,"given":"Aamer","family":"Mohammed","sequence":"first","affiliation":[{"name":"School of Medicine, Royal College of Surgeons in Ireland-Medical University of Bahrain, Busaiteen 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-7589-8972","authenticated-orcid":false,"given":"Yahiya","family":"Baig","sequence":"additional","affiliation":[{"name":"School of Medicine, Royal College of Surgeons in Ireland-Medical University of Bahrain, Busaiteen 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5762-3917","authenticated-orcid":false,"given":"Alexandra E.","family":"Butler","sequence":"additional","affiliation":[{"name":"Department of Research, Royal College of Surgeons in Ireland-Medical University of Bahrain, Busaiteen 15503, Bahrain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,19]]},"reference":[{"key":"ref_1","first-page":"83","article-title":"Diverticular Disease: A Review on Pathophysiology and Recent Evidence","volume":"89","author":"Piscopo","year":"2020","journal-title":"Ulst. Med. J."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1053\/j.gastro.2018.12.033","article-title":"Epidemiology, Pathophysiology, and Treatment of Diverticulitis","volume":"156","author":"Strate","year":"2019","journal-title":"Gastroenterology"},{"key":"ref_3","first-page":"9","article-title":"Epidemiology of diverticular disease\u2014Systematic review of the literature","volume":"110","author":"Stoica","year":"2015","journal-title":"Chirurgia"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/0006-291X(65)90320-7","article-title":"A soluble protein characteristic of the nervous system","volume":"19","author":"Moore","year":"1965","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/nm1638","article-title":"Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock","volume":"13","author":"Vogl","year":"2007","journal-title":"Nat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1136\/gutjnl-2021-324855","article-title":"Calprotectin: From biomarker to biological function","volume":"70","author":"Jukic","year":"2021","journal-title":"Gut"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s00384-008-0595-9","article-title":"Faecal calprotectin in colonic diverticular disease: A case-control study","volume":"24","author":"Tursi","year":"2009","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2174\/0115748871259008231006071656","article-title":"Role of Fecal Calprotectin in Patients Presenting to the Emergency Department with Abdominal Pain with or without Diarrhea or Rectal Bleeding","volume":"19","author":"Saviano","year":"2024","journal-title":"Rev. Recent Clin. Trials"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1373\/clinchem.2011.177980","article-title":"Diagnostic accuracy of point-of-care fecal calprotectin and immunochemical occult blood tests for diagnosis of organic bowel disease in primary care: The Cost-Effectiveness of a Decision Rule for Abdominal Complaints in Primary Care (CEDAR) study","volume":"58","author":"Kok","year":"2012","journal-title":"Clin. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Elias, S.G., Kok, L., de Wit, N.J., Witteman, B.J., Goedhard, J.G., Romberg-Camps, M.J., Muris, J.W.M., and Moons, K.G.M. (2016). Is there an added value of faecal calprotectin and haemoglobin in the diagnostic work-up for primary care patients suspected of significant colorectal disease? A cross-sectional diagnostic study. BMC Med., 14.","DOI":"10.1186\/s12916-016-0684-5"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1177\/2050640615617636","article-title":"Predictive value of the Diverticular Inflammation and Complication Assessment (DICA) endoscopic classification on the outcome of diverticular disease of the colon: An international study","volume":"4","author":"Tursi","year":"2016","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.5217\/ir.2024.00046","article-title":"Bowel movement alterations predict the severity of diverticular disease and the risk of acute diverticulitis: A prospective, international study","volume":"23","author":"Tursi","year":"2025","journal-title":"Intest. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"45","DOI":"10.15403\/jgld-559","article-title":"Budesonide MMX\u2122 is effective in patients having persistent symptoms and raised fecal calprotectin following treatments for diverticular disease","volume":"28","author":"Tursi","year":"2019","journal-title":"J. Gastrointest. Liver Dis."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00384-014-1884-0","article-title":"Increased faecal calprotectin predicts recurrence of colonic diverticulitis","volume":"29","author":"Tursi","year":"2014","journal-title":"Int. J. Colorectal Dis."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/ueg2.12369","article-title":"Diverticular Inflammation and Complication Assessment classification, CODA score and fecal calprotectin in clinical assessment of patients with diverticular disease: A decision curve analysis","volume":"11","author":"Tursi","year":"2023","journal-title":"United Eur. Gastroenterol. J."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e178","DOI":"10.1097\/MCG.0000000000000980","article-title":"Prolonged Recurrent Abdominal Pain is Associated with Ongoing Underlying Mucosal Inflammation in Patients who had an Episode of Acute Complicated Diverticulitis","volume":"53","author":"Lahat","year":"2019","journal-title":"J. Clin. Gastroenterol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MEG.0000000000002342","article-title":"Randomized control trial on the efficacy of Limosilactobacillus reuteri ATCC PTA 4659 in reducing inflammatory markers in acute uncomplicated diverticulitis","volume":"34","author":"Ojetti","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"216","DOI":"10.23736\/S2724-5985.22.03132-1","article-title":"Performance of a multicompounds nutraceutical formulation in patients with symptomatic uncomplicated diverticular disease","volume":"68","author":"Brandimarte","year":"2022","journal-title":"Minerva Gastroenterol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/0115748871308652240712101604","article-title":"Impact of a Symbiotic Mixture on Moderate-to-severe Diverticular Disease of the Colon","volume":"20","author":"Tursi","year":"2025","journal-title":"Rev. Recent Clin. Trials"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/MEG.0000000000000995","article-title":"Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: A pilot study","volume":"30","author":"Kvasnovsky","year":"2018","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1159\/000513473","article-title":"Elevated Faecal Calprotectin in Patients with a Normal Colonoscopy: Does It Matter in Clinical Practice? A Retrospective Observational Study","volume":"6","author":"Hovstadius","year":"2021","journal-title":"Inflamm. Intest. Dis."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"e228092","DOI":"10.1136\/bcr-2018-228092","article-title":"Microscopic colitis impacts quality of life in older people","volume":"12","author":"Ogundipe","year":"2019","journal-title":"BMJ Case Rep."}],"container-title":["Medical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/3\/406\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:26:06Z","timestamp":1784528766000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3271\/14\/3\/406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,19]]},"references-count":22,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["medsci14030406"],"URL":"https:\/\/doi.org\/10.3390\/medsci14030406","relation":{},"ISSN":["2076-3271"],"issn-type":[{"value":"2076-3271","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,19]]}}}